机构:[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China神经科系统神经内科首都医科大学宣武医院[2]Department of Clinical Epidemiology, Qilu Hospital of Shandong University, Jinan, China
第一作者机构:[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China[*1]Department of Neurology,Xuanwu Hospital, Capital Medical University, No. 45 Changchun St, 100053 Beijing, China
通讯作者:
通讯机构:[1]Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China[*1]Department of Neurology,Xuanwu Hospital, Capital Medical University, No. 45 Changchun St, 100053 Beijing, China
推荐引用方式(GB/T 7714):
Li Hai-Feng,Hu Shi-Min,Lv Ming.Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome.[J].JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.2022,327(4):392-393.doi:10.1001/jama.2021.23003.
APA:
Li Hai-Feng,Hu Shi-Min&Lv Ming.(2022).Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome..JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,327,(4)
MLA:
Li Hai-Feng,et al."Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome.".JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 327..4(2022):392-393